Investors & Media Careers Contact Us Home About Us Our Focus Our Pipeline Our Medicine For Patients/Healthcare Providers Global team based in the U.S. and Canada Overview Management Team Board of Directors Partnering Worldwide Locations Global team based in the U.S. and Canada Aurinia’s drug development team is based out of our corporate headquarters in Victoria, British Columbia, Canada, our U.S. commercial hub in Rockville, Maryland and extends to other areas of the globe. Aurinia Corporate Headquarters #1203-4464 Markham Street Victoria, BC V8Z 7X8 Canada Edmonton Office #201-17873 – 106 A Avenue Edmonton, AB T5S 1V8 Canada United States Office (Commercial HUB) 77 Upper Rock Circle – Suite 700 Rockville, MD 20850 USA © 2021 Aurinia Pharmaceuticals Inc. All Rights Reserved. Privacy Statement Terms of Use Disclaimer Aurinia Compliance Program Sitemap Update Consent

Investors & Media Careers Contact Us Home About Us Our Focus Our Pipeline Our Medicine For Patients/Healthcare Providers Board of Directors Overview Management Team Board of Directors Partnering Worldwide Locations Board of Directors George M. Milne, Jr., Ph.D. Chairman of the Board Brinda Balakrishnan, M.D., Ph.D. Director Daniel Billen, Ph.D. Director R. Hector MacKay-Dunn, J.D., Q.C. Director Peter Greenleaf Chief Executive Officer, Director Joseph P. Hagan Director David R.W. Jayne, M.D., FRCP, FRCPE, FMedSci Director Jill Leversage Director Timothy P. Walbert Director © 2021 Aurinia Pharmaceuticals Inc. All Rights Reserved. Privacy Statement Terms of Use Disclaimer Aurinia Compliance Program Sitemap Update Consent